Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ironwood Pharmaceuti (IRWD)

Ironwood Pharmaceuti (IRWD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,525,106
  • Shares Outstanding, K 158,206
  • Annual Sales, $ 428,410 K
  • Annual Income, $ 21,510 K
  • 60-Month Beta 1.75
  • Price/Sales 3.72
  • Price/Cash Flow 17.42
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.10
  • Number of Estimates 1
  • High Estimate 0.10
  • Low Estimate 0.10
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +138.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.99 +23.15%
on 03/18/20
12.31 -20.03%
on 03/09/20
-2.39 (-19.54%)
since 03/06/20
3-Month
7.99 +23.15%
on 03/18/20
13.23 -25.62%
on 02/13/20
-3.31 (-25.17%)
since 01/08/20
52-Week
7.91 +24.40%
on 10/02/19
14.10 -30.21%
on 12/26/19
-2.26 (-18.68%)
since 04/08/19

Most Recent Stories

More News
Ironwood Pharmac Has Returned 18.0% Since SmarTrend Recommendation (IRWD)

SmarTrend identified a Downtrend for Ironwood Pharmac (NASDAQ:IRWD) on January 27th, 2020 at $12.21. In approximately 2 months, Ironwood Pharmac has returned 18.03% as of today's recent price of $10.01....

IRWD : 9.84 (+2.07%)
Global Constipation Treatment Drug Market 2019 Industry Segmentation, CAGR Status, Leading Trends, and Forecast To 2025

The report provides rational insights along with historical and forecast data to said in better understanding of the Global Constipation Treatment Drug Market. The report provides a comprehensive analysis...

ABT : 84.95 (+3.69%)
ALBO : 16.40 (+10.14%)
BAYRY : 15.3600 (-0.78%)
IRWD : 9.84 (+2.07%)
PBH : 40.27 (+4.79%)
SCMP : 18.05 (+0.28%)
SGYP : 0.03 (-52.00%)
VRX.TO : 30.80 (-3.33%)
Ironwood Pharmaceuticals Provides Update on Impact of COVID-19

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today provided an update on certain impacts of COVID-19 on its business and the actions it is taking to mitigate the spread...

IRWD : 9.84 (+2.07%)
Shares of Alkermes Plc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (ALKS , HRTX , IRWD , ICPT , BLUE )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ALKS : 15.83 (+6.46%)
HRTX : 13.97 (+3.10%)
IRWD : 9.84 (+2.07%)
Ironwood (IRWD) Down 22.1% Since Last Earnings Report: Can It Rebound?

Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IRWD : 9.84 (+2.07%)
Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology

--- IW-3718 is currently in two Phase III trials; top line data targeted for second half of 2020 -

IRWD : 9.84 (+2.07%)
Ironwood Pharmac Shares Down 9.4% Since SmarTrend's Sell Call (IRWD)

SmarTrend identified a Downtrend for Ironwood Pharmac (NASDAQ:IRWD) on January 27th, 2020 at $12.21. In approximately 1 month, Ironwood Pharmac has returned 9.38% as of today's recent price of $11.06....

IRWD : 9.84 (+2.07%)
Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present corporate updates at two upcoming investor conferences in March:

IRWD : 9.84 (+2.07%)
Ironwood Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at 9:30 a.m. Eastern Time at the Lotte...

IRWD : 9.84 (+2.07%)
Ironwood (IRWD) Surpasses Q4 Earnings and Sales Estimates

Ironwood (IRWD) witnesses strong demand for Linzess in the fourth quarter as well. Stock up.

IRWD : 9.84 (+2.07%)
AZN : 43.85 (+1.74%)
AGN : 181.08 (+1.58%)
CYCN : 2.82 (+9.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Trade IRWD with:

Business Summary

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome...

See More

Key Turning Points

2nd Resistance Point 10.38
1st Resistance Point 10.11
Last Price 9.84
1st Support Level 9.60
2nd Support Level 9.36

See More

52-Week High 14.10
Fibonacci 61.8% 11.74
Fibonacci 50% 11.01
Fibonacci 38.2% 10.27
Last Price 9.84
52-Week Low 7.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar